Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond2Department of Psychiatry, Virginia Commonwealth University, Richmond3Department of Human and Molecular Genetics, Virginia Commonwealth University, Richm.
Center for Primary Health Care Research, Lund University, Malmö, Sweden.
JAMA Psychiatry. 2014 Apr;71(4):439-45. doi: 10.1001/jamapsychiatry.2013.4166.
Peer deviance (PD) strongly predicts externalizing psychopathologic conditions but has not been previously assessable in population cohorts. We sought to develop such an index of PD and to clarify its effects on risk of drug abuse (DA).
To examine how strongly PD increases the risk of DA and whether this community-level liability indicator interacts with key DA risk factors at the individual and family levels.
DESIGN, SETTING, AND PARTICIPANTS: Studies of future DA registration in 1,401,698 Swedish probands born from January 1, 1970, through December 31, 1985, and their adolescent peers in approximately 9200 small community areas. Peer deviance was defined as the proportion of individuals born within 5 years of the proband living in the same small community when the proband was 15 years old who eventually were registered for DA.
Drug abuse recorded in medical, legal, or pharmacy registry records.
Peer deviance was associated with future DA in the proband, with rates of DA in older and male peers more strongly predictive than in younger or female peers. The predictive power of PD was only slightly attenuated by adding measures of community deprivation, collective efficacy, or family socioeconomic status. Probands whose parents were divorced were more sensitive to the pathogenic effects of high PD environments. A robust positive interaction was also seen between genetic risk of DA (indexed by rates of DA in first-, second-, and third-degree relatives) and PD exposure.
With sufficient data, PD can be measured in populations and strongly predicts DA. In a nationwide sample, risk factors at the level of the individual (genetic vulnerability), family (parental loss), and community (PD) contribute substantially to risk of DA. Individuals at elevated DA risk because of parental divorce or high genetic liability are more sensitive to the pathogenic effects of PD. Although the effect of our PD measure on DA liability cannot be explained by standard measures of community or family risk, we cannot, with available data, discriminate definitively between the effect of true peer effects and other unmeasured risk factors.
同伴偏差(PD)强烈预测外化的精神病理状况,但以前无法在人群队列中评估。我们试图开发这样一个 PD 指数,并阐明其对药物滥用(DA)风险的影响。
研究 PD 如何强烈增加 DA 的风险,以及这种社区水平责任指标是否与个体和家庭层面的关键 DA 风险因素相互作用。
设计、设置和参与者:对 1401698 名 1970 年 1 月 1 日至 1985 年 12 月 31 日出生的瑞典先证者及其青少年同伴的未来 DA 登记进行研究,这些先证者和同伴居住在大约 9200 个小社区。同伴偏差被定义为先证者 15 岁时,与其同一年龄段出生的、居住在同一小社区的个体中最终被登记为 DA 的比例。
在医疗、法律或药房登记记录中记录的药物滥用。
同伴偏差与先证者未来的 DA 相关,年龄较大和男性同伴的 DA 发生率比年龄较小或女性同伴更具预测性。通过添加社区贫困、集体效能或家庭社会经济地位的措施,PD 的预测能力仅略有减弱。父母离异的先证者对高 PD 环境的致病影响更为敏感。还观察到 DA 遗传风险(由一级、二级和三级亲属的 DA 发生率指数化)与 PD 暴露之间存在稳健的正交互作用。
有足够的数据,可以在人群中测量 PD,并强烈预测 DA。在全国性样本中,个体(遗传易感性)、家庭(父母离异)和社区(PD)层面的风险因素对 DA 风险有很大贡献。由于父母离异或高遗传易感性而处于高 DA 风险的个体对 PD 的致病影响更为敏感。虽然我们的 PD 测量对 DA 易感性的影响不能用标准的社区或家庭风险测量来解释,但根据现有数据,我们不能明确区分真正的同伴效应和其他未测量的风险因素的影响。